Breaking AI & Tech News Analyzed

Judith Rapoport, a leading child psychiatrist, passed away at 92, leaving a legacy defined by her groundbreaking work on obsessive‑compulsive disorder (OCD). Her 1989 book, The Boy Who Couldn’t Stop Washing, translated into more than twenty languages, presented complex research in a clear, jargon‑free style that resonated with a broad audience. OCD is characterized by compulsive rituals—re‑tying shoelaces, repeatedly checking switches, or incessant hand‑washing—that can dominate a person’s daily life. Before Rapoport’s book, many sufferers concealed their symptoms out of shame, unaware that they were not alone. Rapoport’s research demonstrated that OCD has a neurological foundation and may affect up to 2% of the population, challenging prevailing beliefs that it stemmed from overly strict parenting. She proved that the disorder can be hereditary and responsive to medication. In a pivotal 1989 double‑blind trial, she showed that the antidepressant clomipramine significantly reduced OCD symptoms, prompting the U.S. Food and Drug Administration to approve its use for the condition—a landmark moment in psychiatric treatment. Patients and colleagues credit her work with reducing stigma. "Reading Rapoport’s book washed away my shame," recalled Charles Gentz, who lives with OCD, while Professor Gabrielle Shapiro of the Icahn School of Medicine noted that the book “reduced the stigma for these people.” Rapoport herself reflected, “If my work alleviated just part of their pain, then it was not wasted time.” Born in New York City to a schoolteacher mother and a businessman father, she grew up with a literary lineage—her grandfather translated Ibsen into Yiddish. She excelled academically, graduating magna cum laude from Swarthmore College in 1955** and earning her medical degree from Harvard Medical School in 1959, where she met her husband, Stanley Rapoport. After early positions at Mount Sinai and the Massachusetts Mental Health Center, she and her husband secured fellowships in Sweden, conducting research at Uppsala University and the Karolinska Institute on women seeking abortions abroad. Returning to the United States, Rapoport joined the National Institute of Mental Health (NIMH) in 1976. There she led the institute’s child psychiatry branch from 1984, steering American psychiatry away from Freudian models toward a **biology‑focused** approach. Beyond OCD, she made significant contributions to the understanding of attention‑deficit hyperactivity disorder (ADHD) and childhood schizophrenia. Her 1978 study revealed that amphetamine improved concentration in both hyperactive and control children, contradicting the notion that stimulants only calm hyperactivity. Using MRI, she showed that childhood schizophrenia is progressive, involving loss of brain matter—a finding that shifted the focus from parenting to neurobiology. Rapoport’s expertise reached mainstream audiences through appearances on shows hosted by Oprah Winfrey and Larry King, further amplifying her message. By the time she retired in 2017, she had authored over 300 scientific papers, several books, and earned prestigious honors, including fellowship in the Institute of Medicine (1991) and the American Academy of Arts and Sciences (2000). Colleague Gabrielle Shapiro described her as “a pioneer who turned child psychiatry into a modern, evidence‑based discipline.” Outside the laboratory, she enjoyed music, theatre, hiking, and gardening. She is survived by her husband, two sons, and four grandsons.

The U.S. Food and Drug Administration announced on Wednesday that it has granted expedited approval to Eli Lilly’s oral weight‑loss medication, orforglipron—marketed under the brand name Foundayo. This makes Foundayo the second GLP‑1 pill to reach U.S. consumers, following Novo Nordisk’s Wegovy tablet approved in December. Orforglipron works by mimicking a natural hormone that regulates appetite and satiety, offering a non‑injectable alternative to existing GLP‑1 injectables. David A. Ricks, Eli Lilly’s chair and CEO, highlighted that fewer than one in ten eligible patients are currently using GLP‑1 therapies, citing barriers such as cost, stigma, and perceived complexity. Unlike Wegovy, which must be taken on an empty stomach each morning, Foundayo can be taken anytime of day regardless of meals, simplifying dosing schedules. Patients will start on a low dose that is gradually increased to mitigate side‑effects. Pricing is projected at $149 per month for the initial dose, with higher‑strength formulations potentially reaching $349 monthly. While private‑insurance coverage remains uncertain, a Trump‑administration proposal could allow Medicare to cover certain patients as early as this summer, with copayments as low as $50 per month. Distribution will commence on Monday through LillyDirect’s direct‑to‑consumer channel, with broader availability in pharmacies and telehealth platforms expected shortly thereafter. The convenience of a once‑daily pill is anticipated to improve adherence, especially for individuals who avoid injectables due to needle aversion or rigid dosing requirements. The approval follows a fast‑track submission submitted only months ago, positioning Foundayo to enter the market roughly three months after Wegovy. This rapid rollout is set to intensify competition in the burgeoning GLP‑1 space, where new agents are continually emerging with claims of better efficacy and lower costs.

The BBC series 'Babies' is redefining television storytelling by tackling the sensitive topic of miscarriage with a unique blend of realism and emotional depth. Created by Stefan Golaszewski, the show follows a couple, Lisa and Stephen, as they navigate the aftermath of a miscarriage and the challenges of expressing their grief.Golaszewski's approach to the subject matter is characterized by his meticulous attention to detail and commitment to recreating real life on screen. The show's cast, including Siobhán Cullen and Paapa Essiedu, praise Golaszewski's dedication to authenticity, which involved painstaking planning and a focus on naturalistic dialogue.The series explores themes of male friendship and the difficulties of expressing vulnerability, as well as the societal stigma surrounding miscarriage. Golaszewski hopes that 'Babies' will contribute to a broader conversation about miscarriage awareness and help to reduce the sense of isolation that many people experience after suffering a miscarriage.The show's use of naturalistic storytelling and emotional depth has been praised by critics and audiences alike, with many noting its impact on their perspective on miscarriage and its effects on individuals and relationships.

In a poignant tale of love and resilience, a Ugandan mother has taken a stand against the societal stigma surrounding disability, fiercely advocating for her son Aaron. Her journey is a testament to the power of maternal love and the fight for inclusivity.The mother's unwavering dedication to her child has led her to confront deeply ingrained cultural and social norms that often marginalize individuals with disabilities. By sharing her story, she aims to inspire change and promote acceptance.This heart-wrenching yet uplifting narrative sheds light on the challenges faced by families with children with disabilities in Uganda, highlighting the need for greater awareness and support. Through her courage, this remarkable mother is helping to pave the way for a more inclusive and compassionate society.

The announcement of BTS's comeback album has transported me back to a bygone era, one marked by all-consuming passion and a dash of secrecy. As a teenager, I was deeply invested in K-pop, particularly BTS, but I often found myself hiding this obsession from peers due to fear of ridicule. In those days, it was uncommon for groups of girls to openly discuss or watch new music videos from popular K-pop bands like BTS or One Direction. We'd often gather in private settings, like late-night Skype calls or in the back of a classroom, to share and enjoy our favorite content. This clandestine nature of fandom was partly due to the stigma attached to being a 'fan girl.' The author recalls feeling self-conscious about their enthusiasm and downplaying it to avoid being labeled as 'crazy' or 'obsessed.' This behavior was not unique; many teenage girls have similar experiences, often softening their passions to fit in or avoid criticism. The question remains: why is it that displaying genuine emotion is frequently misconstrued as unhealthy dependence? Looking back, the author feels a sense of protection and softness towards their younger self, who found solace, connection, and belonging through BTS's music and universe. During a particularly challenging time, when the author moved to Melbourne alone at 17, BTS's extensive content provided comfort and something to look forward to. This period of intense fandom ultimately helped the author make meaningful connections and discover creative outlets like writing. The experience was pivotal in their personal development, offering a safe space to express themselves and explore their creativity through fan art, fan fiction, and more. With the release of BTS's new album, Arirang, and a world tour on the horizon, the author is eager to revisit their teenage self, embracing the excitement and joy that comes with being a fan. This nostalgia-tinged comeback is not just about the music; it's about reconnecting with a part of themselves that they had set aside.